Presentation TCT 2025 TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis Presenter: Mahsa Rezasoltani October 26, 2025
Presentation TCT 2025 TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis Presenter: Mahmoud Abdelnabi October 25, 2025
Presentation TCT 2025 TCT 749: Renal Protective Effects of SGLT2 Inhibitors After Transcatheter Mitral Valve Repair in Patients with Type 2 Diabetes Mellitus: A Propensity-Matched Retrospective Analysis Presenter: Mahmoud Abdelnabi October 25, 2025
Presentation TCT 2025 Abluminus Sirolimus DES+ vs. Everolimus-Eluting Stents in Patients with Diabetes Mellitus: Final 2-Year Results of the ABILITY Global Study Presenter: Alexandre Abizaid October 25, 2025
Presentation TCT India 2025 Landmark Trial/Compare TAVI trials Presenter: Nagendra Chauhan July 27, 2025
Presentation TCT India 2025 No Ctrl+Z in the Cath Lab: Decisions, Disaster, and Deliverance Presenter: Rajesh Natuva & Ramesh Gudapati July 26, 2025
Presentation TCT India 2025 Cracking The Calcium OCT Guided Rotablation in Action Presenter: Annapoorna Kalia July 26, 2025
Presentation TCT India 2025 Hybrid PCI-Less Metal More Medicine Presenter: Sanjeev Gera July 26, 2025
Presentation TCT India 2025 Remote Monitoring & Cardiac Rehab: The missing link in HF management Presenter: R.R. Mantri July 26, 2025
Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation THT 2025 The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes Presenter: Navneet Sandhu February 12, 2025
Presentation THT 2025 Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study Presenter: Thitiphan Srikulmontri February 12, 2025
Presentation THT Abstracts 2025 The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes Presenter: Navneet Sandhu February 11, 2025
Presentation THT Abstracts 2025 Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study Presenter: Thitiphan Srikulmontri February 11, 2025
Presentation AHA 2024 Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial Presenter: Milton Packer November 16, 2024